GE HealthCare Technologies Inc. (NASDAQ:GEHC) Plans $0.04 Quarterly Dividend

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced a quarterly dividend on Tuesday, June 30th. Investors of record on Friday, July 24th will be paid a dividend of 0.035 per share on Friday, August 14th. This represents a c) annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th.

GE HealthCare Technologies has a dividend payout ratio of 3.0% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect GE HealthCare Technologies to earn $5.36 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.6%.

GE HealthCare Technologies Trading Down 1.6%

Shares of NASDAQ GEHC opened at $64.01 on Wednesday. GE HealthCare Technologies has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a market cap of $29.12 billion, a price-to-earnings ratio of 15.31, a price-to-earnings-growth ratio of 1.77 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock’s 50 day simple moving average is $64.14 and its 200 day simple moving average is $73.62.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts expect that GE HealthCare Technologies will post 4.89 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Citigroup lowered their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Wednesday, April 29th. Finally, Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $80.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.